Review
Published on 07 May 2024
Mechanism of tacrolimus in the treatment of lupus nephritis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1331800
- 183 views
Type at least 3 characters
501 articles
Articles
Original Research
Accepted on 06 May 2024
Improving Glycemic Control: Transitioning from Dulaglutide to Tirzepatide in Patients with Type 2 Diabetes Undergoing Hemodialysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1362242
Original Research
Published on 01 May 2024
Pre-operative maintenance of angiotensin-converting enzyme inhibitors is not associated with acute kidney injury in cardiac surgery patients with cardio-pulmonary bypass: a propensity-matched multicentric analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1343647
- 147 views
Original Research
Accepted on 30 Apr 2024
Pharmacological targets of SGLT2 inhibitors on IgA nephropathy and membranous nephropathy: a Mendelian randomization study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1399881
Original Research
Published on 26 Apr 2024
A Chinese patent medicine’s long-term efficacy on non-dialysis patients with CKD stages 3–5: a retrospective cohort study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1379338
- 200 views
Original Research
Accepted on 24 Apr 2024
Computational drug discovery approaches identify mebendazole as a candidate treatment for Autosomal Dominant Polycystic Kidney Disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1397864
- 149 views
Review
Accepted on 23 Apr 2024
Effects of cell-free DNA on kidney disease and intervention strategies
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377874
Original Research
Accepted on 22 Apr 2024
Mortality prediction and influencing factors for intensive care unit patients with acute tubular necrosis: random survival forest and cox regression analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1361923
Review
Published on 22 Apr 2024
The molecular mechanisms of peptidyl-prolyl cis/trans isomerase Pin1 and its relevance to kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373446
- 352 views
Review
Accepted on 19 Apr 2024
Application of biological agents in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1378384
Original Research
Accepted on 17 Apr 2024
Nimbidiol protects from renal injury by alleviating oxidative stress in diabetic mice
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1369408
Review
Accepted on 05 Apr 2024
Targeting pyruvate kinase M2 for the treatment of kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1376252
- 158 views
Original Research
Published on 27 Mar 2024
Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1358573
- 998 views
Original Research
Published on 27 Mar 2024
Aristolochic acid induces acute kidney injury through ferroptosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1330376
- 592 views
Systematic Review
Published on 26 Mar 2024
Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1373258
- 623 views
Systematic Review
Published on 21 Mar 2024
Efficacy of traditional Chinese medicine versus angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and their combinations in the treatment of IgA nephropathy: a systematic review and network meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1374377
- 497 views